BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6444612)

  • 1. Pure bovine granulocytes as a source of granulopoiesis inhibitor (chalone).
    Kastner M; Maurer HR
    Hoppe Seylers Z Physiol Chem; 1980; 361(2):197-200. PubMed ID: 6444612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation, identification and mechanism of action of the granulocytic chalone.
    Paukovits WR; Paukovits JB
    Boll Ist Sieroter Milan; 1975 Jul; 54(3):177-86. PubMed ID: 130142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulocyte chalone: tissue specificity of action in short-term cultures].
    Schunck H; Schütt M; Langen P
    Acta Biol Med Ger; 1978; 37(4):593-600. PubMed ID: 153696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation system of granulopoiesis.
    Paukovits WR
    Osterr Z Onkol; 1977 Oct; 4(2-3):52-4. PubMed ID: 145565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulocytic chalone and antichalone as homeostatic factors in the functional system of the blood in aseptic inflammation].
    Bala IuM; Lifshits VM; Sidel'nikova VI
    Patol Fiziol Eksp Ter; 1988; (5):39-41. PubMed ID: 2975373
    [No Abstract]   [Full Text] [Related]  

  • 6. Starting procedures for the isolation and purification of granulocyte chalone activities.
    Maurer HR; Weiss G; Laerum D
    Blut; 1976 Sep; 33(3):161-70. PubMed ID: 134753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specificity and mechanism of action of the granulocyte chalon and its role in the regulatory system of granulopoiesis].
    Paukovits WR
    Osterr Z Onkol; 1975; 2(2-3):51-6. PubMed ID: 128729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic chalone is not a polyamine complex.
    Foa P; Paile W; Yuen TL; Jones WA; Jänne J; Rytömaa T
    Biomedicine; 1979 Oct; 31(6):163-7. PubMed ID: 160803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous factors possessing lymphoid chalone properties, purified by chromatography.
    Privat de Garilhe M; Vedel M; Tempête C; Federici C; Garcia-Giralt E
    Biomedicine; 1980 Oct; 32(3):148-54. PubMed ID: 6449966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulopoiesis-inhibiting factor: demonstration and preliminary chemical and biological characterization of a specific polypeptide (chalone).
    Paukovits WR
    Natl Cancer Inst Monogr; 1973 Jul; 38():147-55. PubMed ID: 4271038
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for specific calf thymus inhibitors (chalones) of T-lymphocyte proliferation.
    Maschler R; Maurer HR
    Hoppe Seylers Z Physiol Chem; 1979 Jun; 360(6):735-45. PubMed ID: 157318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of maturation inhibiting compound in bovine follicular fluid.
    Dostál J; Pavlok A
    Reprod Nutr Dev; 1996; 36(6):681-90. PubMed ID: 9021879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solubility properties of granulopoiesis inhibiting factor.
    Paukovits WR; Paukovits JB
    Experientia; 1975 Nov; 31(11):1357-9. PubMed ID: 128468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of lymphocytic chalone on lymphocyte functional activity in antioxidant deficiency and its correction with vitamin E].
    Harkava KH; Afonina HB; Zadorina OV; Briuzhina TS
    Fiziol Zh (1994); 1995; 41(5-6):27-32. PubMed ID: 9026388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variations in the committed stem cell responsiveness to granulopoiesis inhibitory factor (chalone) in vitro.
    Aardal NP; Laerum OD; Paukovits WR
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(3):247-55. PubMed ID: 6141658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of a chalone-containing esophageal preparation on its epithelial cell proliferation].
    Torshina IG; Romanov IuA
    Biull Eksp Biol Med; 1986 Dec; 102(12):749-51. PubMed ID: 2948573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between the mitosis-inhibitory activity of a chalone preparation of Ehrlich ascites tumor and its diurnal secretion].
    Bogoeva MV; Antokhin AI; Romanov IuA
    Biull Eksp Biol Med; 1981 Mar; 91(3):343-5. PubMed ID: 6454450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte chalone assayed in vivo in the mouse.
    Perrins DJ; Wiernik G; Jones WA
    Acta Haematol; 1980; 64(2):72-8. PubMed ID: 6449128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.